Herbalife (HLF) Raised to “Buy” at Zacks Investment Research

Herbalife (NYSE:HLF) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Thursday. The brokerage currently has a $108.00 target price on the stock. Zacks Investment Research‘s price target points to a potential upside of 8.51% from the stock’s current price.

According to Zacks, “Herbalife is a global network marketing company offering a range of science-based weight management products, nutritional supplements and personal care products intended to support weight loss and a healthy lifestyle. “

How to Become a New Pot Stock Millionaire

Several other research firms have also recently commented on HLF. ValuEngine upgraded shares of Herbalife from a “buy” rating to a “strong-buy” rating in a report on Wednesday, November 22nd. SunTrust Banks restated a “hold” rating and set a $67.00 price target on shares of Herbalife in a report on Friday, November 10th. Pivotal Research restated a “buy” rating and set a $120.00 price target on shares of Herbalife in a report on Thursday, January 25th. Citigroup upgraded shares of Herbalife from a “neutral” rating to a “buy” rating and raised their price target for the stock from $85.00 to $114.00 in a report on Monday, March 5th. Finally, TheStreet cut shares of Herbalife from a “b-” rating to a “c” rating in a report on Monday, March 5th. Two investment analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $104.60.

Herbalife (NYSE HLF) opened at $99.53 on Thursday. Herbalife has a fifty-two week low of $50.70 and a fifty-two week high of $99.67. The company has a market cap of $8,680.00, a PE ratio of 22.17 and a beta of 1.20. The company has a quick ratio of 1.68, a current ratio of 2.05 and a debt-to-equity ratio of -6.47.

Herbalife (NYSE:HLF) last announced its earnings results on Thursday, February 22nd. The company reported $1.29 EPS for the quarter, topping the consensus estimate of $0.96 by $0.33. Herbalife had a net margin of 4.83% and a return on equity of 457.78%. The company had revenue of $1.09 billion during the quarter, compared to analysts’ expectations of $1.08 billion. During the same period last year, the company posted $1.00 earnings per share. The business’s revenue for the quarter was up 4.6% on a year-over-year basis. sell-side analysts predict that Herbalife will post 5.3 EPS for the current year.

In other Herbalife news, insider Shin-Shing Bosco Chiu sold 2,380 shares of Herbalife stock in a transaction that occurred on Wednesday, December 13th. The shares were sold at an average price of $69.98, for a total value of $166,552.40. Following the completion of the sale, the insider now directly owns 5,000 shares in the company, valued at $349,900. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Thomas Harms sold 8,532 shares of Herbalife stock in a transaction that occurred on Friday, December 29th. The shares were sold at an average price of $68.49, for a total transaction of $584,356.68. Following the completion of the sale, the senior vice president now owns 1,000 shares of the company’s stock, valued at $68,490. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 104,143 shares of company stock valued at $8,785,829. 4.95% of the stock is currently owned by corporate insiders.

Hedge funds and other institutional investors have recently bought and sold shares of the business. American International Group Inc. acquired a new stake in Herbalife in the fourth quarter valued at approximately $103,000. Opera Trading Capital acquired a new stake in Herbalife in the third quarter valued at approximately $185,000. The Manufacturers Life Insurance Company lifted its stake in Herbalife by 7.2% in the second quarter. The Manufacturers Life Insurance Company now owns 2,821 shares of the company’s stock valued at $201,000 after acquiring an additional 189 shares during the last quarter. FDx Advisors Inc. acquired a new stake in Herbalife in the third quarter valued at approximately $227,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Herbalife by 36.5% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,445 shares of the company’s stock valued at $233,000 after acquiring an additional 922 shares during the last quarter. Hedge funds and other institutional investors own 98.92% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece of content was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://sportsperspectives.com/2018/03/10/herbalife-hlf-raised-to-buy-at-zacks-investment-research.html.

Herbalife Company Profile

Herbalife Ltd. is a global nutrition company. The Company develops and sells weight management, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, as well as personal care products. Its operating segments are based on geographical operations in six regions: North America; Mexico; South and Central America; Europe, the Middle East, and Africa (EMEA); Asia Pacific, and China.

Get a free copy of the Zacks research report on Herbalife (HLF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Herbalife (NYSE:HLF)

Receive News & Ratings for Herbalife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply